News
FAPESP and MRC selected project on Zika Versão em português
To better understand the nature of the risk posed by the Zika virus, FAPESP and UK Medical Research Council (MRC) launched on February a rapid response funding initiative and now announce the result of the call.
It is critical that robust evidence for the risks associated with Zika transmission and infection are obtained as soon as possible, to ensure that optimal management and prevention measures can be established.
To support the collection of such evidence, the MRC is launching a £1m rapid response initiative, funded by the recently announced Global Challenges Research Fund, for investigators who are ready and able to undertake timely and appropriate studies on the Zika virus and epidemic.
FAPESP will provide support through Regular Grant Awards so the project can provide novel, critical and timely insights into the nature of the risk posed by the Zika virus and/or potential paths for its management or prevention.
Researchers |
Project |
João Santana da Silva Daniel Martin Altmann |
CD4 T cell immune correlates of Zika virus exposure FAPESP grant number: 2016/50123-0 |
More information is available in the call for proposals at: www.fapesp.br/10040.